CHA Hollywood Presbyterian Medical Center Opens First Dedicated Hospital-Based Ophthalmic Operating Room in Los Angeles County

CHA Hollywood Presbyterian Medical Center (CHA HPMC), a hospital that is a member of CHA Health Systems, a global network providing a full spectrum of dynamic healthcare services, announced the opening of a state-of-the-art ophthalmic surgery suite as part of the hospital’s Southern California Eye Institute.

The new hospital-based ophthalmic operating room is the first hospital-based facility dedicated to eye surgery in the Los Angeles area.

Regarding the hospital-based ophthalmic operating room, Rohit Varma, MD, MPH, director of Southern California Eye Institute said, “As a team, we’ve taken bold steps to create a premier surgical suite that will offer the latest advancements and technology while focusing on patient experience and outcomes.”

The surgical suite is designed to create a seamless experience for patients and families. The operating rooms will be fully equipped with new state-of-the-art laser only cataract technology by early 2020, which will enable more precise intraocular implant measurements. The dedicated operating room will also have its own scheduling system, enabling convenient, faster scheduling for patients and community ophthalmologists.

“We’re very excited to finally have two ophthalmology-exclusive operating rooms available for patients and healthcare providers,” said Jacob Reznik, MD, a cataract and refractive surgery specialist who will oversee the surgery suite. “We will work closely with our colleagues and CHA HPMC physicians to continue building upon this center of excellence in ophthalmic surgery.”

With the laser-assisted cataract surgery technology, ophthalmic surgeons will be able to perform minimally invasive surgeries. New suite will also enable the performance of advanced glaucoma surgical tubes and trabeculectomies including XenGel implantation, microincisional glaucoma surgery including iStent, Hydrus, Kahook dual-blade (KDB) OMNI, and micropulse laser. Advanced retinal procedures will include small incision sutureless vitrectomy, epiretinal membrane surgery, and advanced diabetic disease procedures. Innovative oculofacial plastic surgery procedures will include ptosis (droopy eyelid), blepharoplasty (excess skin), ectropion (eyelid turning out), entropion (eyelid turning in), eyelid tumors, thyroid eye disease, tearing problems, facial trauma, and orbital tumors. The cutting edge therapy using the newest advanced technology will reduce surgical times and enable quick recovery for patients to return to their daily activities quickly.

“We are on a continual mission to create better ways — and embarked on a $400 million master plan slated for completion by 2021. We are making huge investments in the facility to develop Centers of Excellence, innovative technology, and people to better serve our Los Angeles community and be the medical center of the future,” said Robert Allen, CHA Hollywood Presbyterian Medical Center president and chief executive officer.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Tabrecta is the first FDA-approved therapy to treat non small cell lung cancer with specific mutations (those that lead to mesenchymal-epithelial transition or MET exon 14 skipping).
The Cor® TRICUSPID ECM® valve has been successfully implanted in the 11th patient enrolled in the expansion by Dr. Marc Gerdisch, Chief of Cardiothoracic Surgery at Franciscan Health Heart Center in Indianapolis, Indiana & principal investigator for the adult component of the study.
Thirona notes LungQ 3.0.0 builds on 10 years of clinical trials and 200+ publications to deliver advanced segmentation of pulmonary segments and subsegments.
The Zeta Surgical Cranial Navigation System is a mixed-reality navigation system for neurosurgery, providing surgeons with "GPS-like" guidance with millimetric accuracy in real-time. Zeta's computer vision engine ensures maintained accuracy by automatically registering multiple times a second, accounting for patient movement, and allowing for awake and non-immobilized use in both operative and extra-operative settings.
The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements.

By using this website you agree to accept Medical Device News Magazine Privacy Policy